Antigen production and development of an indirect ELISA based on the nucleocapsid protein to detect human SARS-CoV-2 seroconversion

Serological assays are important tools to identify previous exposure to SARS-CoV-2, helping to track COVID-19 cases and determine the level of humoral response to SARS-CoV-2 infections and/or immunization to future vaccines. Here, the SARS-CoV-2 nucleocapsid protein was expressed in Escherichia coli...

Descripción completa

Detalles Bibliográficos
Autores principales: Conzentino, Marcelo S., Forchhammer, Karl, Souza, Emanuel M., Pedrosa, Fábio O., Nogueira, Meri B., Raboni, Sônia M., Rego, Fabiane G. M., Zanette, Dalila L., Aoki, Mateus N., Nardin, Jeanine M., Fornazari, Bruna, Morales, Hugo M. P., Celedon, Paola A. F., Lima, Carla V. P., Mattar, Sibelle B., Lin, Vanessa H., Morello, Luis G., Marchini, Fabricio K., Reis, Rodrigo A., Huergo, Luciano F.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer International Publishing 2021
Materias:
Clinical Microbiology - Short Communication
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8329412/
https://www.ncbi.nlm.nih.gov/pubmed/34342836
http://dx.doi.org/10.1007/s42770-021-00556-6

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8329412/
https://www.ncbi.nlm.nih.gov/pubmed/34342836
http://dx.doi.org/10.1007/s42770-021-00556-6

Ejemplares similares